Area of research
Surgery · Molecular Biology
Research interest
Research interests include Esophageal Cancer Research and Treatment, RNA modifications and cancer, Lung Cancer Treatments and Mutations, and Cancer-related molecular mechanisms research.
Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers
TP53 Mutations in Esophageal Squamous Cell Carcinoma
Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation
PD1<sup>hi</sup> CD200<sup>hi</sup> CD4<sup>+</sup> exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial–mesenchymal transition in bladder cancer
CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling
Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1
Myeloid-derived suppressor cells promote lung cancer metastasis by CCL11 to activate ERK and AKT signaling and induce epithelial-mesenchymal transition in tumor cells
Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
Lnc-GAN1 expression is associated with good survival and suppresses tumor progression by sponging mir-26a-5p to activate PTEN signaling in non-small cell lung cancer
An Approach to Accelerate Healing and Shorten the Hospital Stay of Patients With Anastomotic Leakage After Esophagectomy: An Explorative Study of Systematic Endoscopic Intervention
Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China
Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing
The correlations of tumor mutational burden among single-region tissue, multi-region tissues and blood in non-small cell lung cancer
Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy
CD215+ Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression
The chemokine CXCL13 in lung cancers associated with environmental polycyclic aromatic hydrocarbons pollution
Tobacco smoke induces production of chemokine CCL20 to promote lung cancer
Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
Ethoxysanguinarine Induces Inhibitory Effects and Downregulates CIP2A in Lung Cancer Cells